Skip to main content
Wilk Technologies Ltd. logo

Wilk Technologies Ltd. — Investor Relations & Filings

Ticker · WILK ISIN · IL0002780109 LEI · 5493009GENSF7UJRHB07 TA Manufacturing
Open in API
Filings indexed 27 across all filing types
Latest filing 2026-04-05 Regulatory Filings
Country IL Israel
Listing TA WILK

About Wilk Technologies Ltd.

https://wilkismilk.com/

Wilk Technologies Ltd. is a food and biotechnology company specializing in the development of cell-based technologies to produce cultured milk and its components. The company focuses on creating both cultured human breast milk for the infant formula market and cultured animal milk as a sustainable alternative for the dairy industry. Using proprietary methods to cultivate mammary cells, Wilk aims to produce authentic milk ingredients, such as milk fats, that replicate the nutritional profile of conventionally produced milk. This technology is designed to address environmental and supply chain challenges associated with traditional agriculture. The company has demonstrated its capabilities by producing the world's first yogurt using cultured milk fat.

Recent filings

Filing Released Lang Actions
Opening of Trading on April 06 2026-WILK W5
Regulatory Filings Classification · 75% confidence The document is a brief announcement by the Tel Aviv Stock Exchange regarding the commencement of trading in a specific security. It is neither an earnings release nor a financial report, corporate action like share issue wording, nor AGM materials. It does not fit any specific category such as dividend notice or M&A activity. Therefore, it falls under the general regulatory announcement fallback category: Regulatory Filings (RNS).
2026-04-05 English
WILK TECHNOLOGIES LTD-Rights Offering and Identifying Details for New Securities-WILK W5, WILK R1
Share Issue/Capital Change Classification · 100% confidence The document is an official notice from the Tel Aviv Stock Exchange regarding a rights offering for Wilk Technologies Ltd. It details the ex-rights date, the calculation method for the base price, and the identifying details (ISIN, Symbol) for the new securities being issued. This falls under the category of share issues and capital changes.
2026-03-10 English
Court's approval to extend the last exercise date of warrant 3 to December 31, 2024, Trading in the warrant will resume tomorrow, May 27, 2024
Regulatory Filings Classification · 95% confidence The document is a short announcement from the Listing Companies Compliance Unit regarding the trading halt and extension of the exercise date for a warrant of Wilk Technologies Ltd. It mentions the last trading day and the court's approval to change warrant terms, including extending the exercise date. There is no financial data, no detailed report, and the document is brief (696 characters). It also references the company's report being available on the ISA website but does not contain the report itself. This fits the profile of a Regulatory Filing (RNS) as it is a regulatory announcement about trading status and compliance, not a full report or financial statement.
2024-05-26 Hebrew (modern)
Warrant (series 3)-Following court decision, trading in the warrants will open tomorrow as usual
Regulatory Filings Classification · 95% confidence The document is a brief notice from the Tel Aviv Stock Exchange regarding the extension of the exercise period for a company's warrants and the resumption of trading. It references a prior immediate report and a court decision but does not contain financial statements, detailed financial data, or management discussion. The document is short (645 characters) and serves as a regulatory announcement about trading status and compliance. It does not fit into categories like Annual Report, Earnings Release, or Capital/Financing Update. It is best classified as a Regulatory Filing (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2024-05-01 Hebrew (modern)
Warrant (series 3)-Trading will resume after receiving a revised court decision
Regulatory Filings Classification · 95% confidence The document is a short announcement from the Listing Companies Compliance Unit addressed to TASE Members regarding a court decision about the extension of the exercise period of warrants for Wilk Technologies. It mentions trading halts and clerical errors in the court decision, with plans to appeal. There is no financial data, no detailed report, no management discussion, or any other detailed filing content. The document is an official regulatory announcement related to trading and compliance matters. Given its short length (856 characters) and nature as a regulatory update, it fits best under Regulatory Filings (RNS).
2024-04-07 Hebrew (modern)
Investor Presentation - January 2024
Investor Presentation Classification · 98% confidence The document is a highly visual, slide-based presentation containing forward-looking statements, market analysis, product descriptions ("Cow milk without cows," "Human Breastmilk without mothers"), competitive landscapes, and team biographies. It explicitly mentions being a 'presentation' and includes disclaimers typical of investor materials. This structure strongly suggests an Investor Presentation (IP) designed to convey strategy, technology, and market opportunity to potential investors or partners, rather than a formal regulatory filing like a 10-K or an Earnings Release (ER). The content focuses on strategy, technology, and team, fitting the definition of an Investor Presentation.
2024-01-17 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.